IndraLab

Statements


TGFB1 increases the amount of SDC4. 19 / 19
| 19

reach
"Together, these results suggest that the early upregulation of endothelial syndecan-4 expression by TGF-beta 1 is mediated by the ALK5-Smad3-p38 MAPK pathway, whereas the late downregulation is mediated by the ALK5-Smad2/3 pathway."

reach
"To examine the involvement of Smad2 and Smad3 in the modulation of syndecan-4 expression by TGF-beta 1, vascular endothelial cells were transfected with siSmad2 or siSmad3 and then treated with 5ng/mL TGF-beta 1."

reach
"These results indicate that the early upregulation of syndecan-4 mRNA expression by TGF-beta 1 is mediated by Smad3, whereas Smad2 or Smad3 alone is not involved in the late downregulation of syndecan-4 mRNA expression by TGF-beta 1; the late downregulation of syndecan-4 core protein expression by TGF-beta 1 is mediated by Smad3."

reach
"The early upregulation and late downregulation of syndecan-4 mRNA expression by TGF-beta 1 were both not affected by siRNA mediated knockdown of Smad2."

reach
"The results indicated that the siRNA mediated knockdown of both Smad2 and Smad3 diminished the late downregulation of syndecan-4 mRNA expression by TGF-beta 1, although the knockdown of just one could not diminish the downregulation."

reach
"These results and our data, which showed that the induction of endothelial syndecan-4 expression occurs in the early stage of the exposure to TGF-beta 1, suggest that the upregulation of endothelial syndecan-4 expression by TGF-beta 1 may be a defense mechanism against an acute injury to vascular endothelial cells."

reach
"These results suggest that the late downregulation of syndecan-4 expression by TGF-beta 1 is mediated by Smad2/3 at the mRNA level and by Smad3 at the protein level."

reach
"Specifically, the downregulation of syndecan-4 expression by TGF-beta 1 is mediated by the interaction of Smad3 with Smad2 at the mRNA expression level, whereas only Smad3 is crucial at the core protein expression level."

reach
"It is possible that the biphasic regulation of endothelial syndecan-4 expression by TGF-beta 1 is mediated by the Smad pathway, non Smad pathway, or both."

reach
"THE p38 MAPK PATHWAY MEDIATES THE EARLY UPREGULATION OF ENDOTHELIAL SYNDECAN-4 EXPRESSION BY TGF-beta 1."

reach
"Furthermore, SDC4 overexpression enhanced the induction of EMT related genes by the stimulation of TGF-beta1 in the both A549 and NCI-H292 cells."

reach
"Figure XREF_FIG shows the phosphorylation of MAPKs (ERK1/2, JNK, and p38 MAPK) and Smad2/3, which may be involved in the modulation of syndecan-4 expression by TGF-beta 1 as the downstream signaling pathways of the cytokine."

reach
"On the other hand, siRNA mediated knockdown of Smad3 diminished the upregulation of syndecan-4 mRNA expression by TGF-beta 1, suggesting that Smad3 is a member of the signaling pathway that mediates the TGF-beta 1 -induced upregulation of syndecan-4 expression."

reach
"This result is consistent with our recent study [Hara et al., 2016], showing that TGF-beta 1 modulates endothelial syndecan-4 expression in a biphasic manner."

reach
"TGF-beta1 up-regulated the expression of SDC4, accompanied by the induction of EMT."

reach
"In addition, TGF-beta 1 increased syndecan-4 core protein expression in the cell layer, and this increase was completely diminished by SB203580; the core protein was not detected in the conditioned medium."

reach
"To examine the involvement of MAPKs in the modulation of syndecan-4 mRNA expression by TGF-beta 1, vascular endothelial cells were pretreated with the MEK1 inhibitor PD98059, JNK inhibitor SP600125, or p38 MAPK inhibitor SB203580 and then stimulated with TGF-beta 1."

reach
"The late downregulation of syndecan-4 core protein expression by TGF-beta 1 was observed in cells treated with or without siRNA for Smad2, but this downregulation was reduced by siRNA for Smad3."

reach
"They indicated that TGF-beta 1 upregulates syndecan-4 expression via the ALK5-Smad3-p38 MAPK pathway at the early stage, whereas downregulation of the expression occurs via the ALK5-Smad2/3 pathway."